Clinical Trials Logo

Joint Bleed clinical trials

View clinical trials related to Joint Bleed.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06155955 Recruiting - Clinical trials for Severe Hemophilia A Without Inhibitor

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

Start date: June 22, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

- To outcome between low dose Emicizumab and low dose prophylaxis with FVIII concentration - To study pharmacokinetic, side effect of low dose Emicizumab